United States Sjogren’s Syndrome Market Report 2017

January 2017 | 98 pages | ID: U79E1382851EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Sjogren’s Syndrome

Revenue, means the sales value of Sjogren’s Syndrome

This report studies sales (consumption) of Sjogren’s Syndrome in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Astellas Pharma
• Roche
• Novartis
• Pfizer
• GSK
• Genzyme (Sanofi)?

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Biologic immunosuppressant drugs
• Others

Split by applications, this report focuses on sales, market share and growth rate of Sjogren’s Syndrome in each application, can be divided into

• Eye care
• Vaginal dryness
• Musculoskeletal
• Systemic
• Dental care

Contents

United States Sjogren’s Syndrome Market Report 2017

1 SJOGREN’S SYNDROME OVERVIEW

1.1 Product Overview and Scope of Sjogren’s Syndrome
1.2 Classification of Sjogren’s Syndrome
  1.2.1 Biologic immunosuppressant drugs
  1.2.2 Others
1.3 Application of Sjogren’s Syndrome
  1.3.1 Eye care
  1.3.2 Vaginal dryness
  1.3.3 Musculoskeletal
  1.3.4 Systemic
  1.3.5 Dental care
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Sjogren’s Syndrome (2011-2021)
  1.4.1 United States Sjogren’s Syndrome Sales and Growth Rate (2011-2021)
  1.4.2 United States Sjogren’s Syndrome Revenue and Growth Rate (2011-2021)

2 UNITED STATES SJOGREN’S SYNDROME COMPETITION BY MANUFACTURERS

2.1 United States Sjogren’s Syndrome Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Sjogren’s Syndrome Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Sjogren’s Syndrome Average Price by Manufactures (2015 and 2016)
2.4 Sjogren’s Syndrome Market Competitive Situation and Trends
  2.4.1 Sjogren’s Syndrome Market Concentration Rate
  2.4.2 Sjogren’s Syndrome Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES SJOGREN’S SYNDROME SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2011-2016)

3.1 United States Sjogren’s Syndrome Sales and Market Share by States (2011-2016)
3.2 United States Sjogren’s Syndrome Revenue and Market Share by States (2011-2016)
3.3 United States Sjogren’s Syndrome Price by States (2011-2016)

4 UNITED STATES SJOGREN’S SYNDROME SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

4.1 United States Sjogren’s Syndrome Sales and Market Share by Type (2011-2016)
4.2 United States Sjogren’s Syndrome Revenue and Market Share by Type (2011-2016)
4.3 United States Sjogren’s Syndrome Price by Type (2011-2016)
4.4 United States Sjogren’s Syndrome Sales Growth Rate by Type (2011-2016)

5 UNITED STATES SJOGREN’S SYNDROME SALES (VOLUME) BY APPLICATION (2011-2016)

5.1 United States Sjogren’s Syndrome Sales and Market Share by Application (2011-2016)
5.2 United States Sjogren’s Syndrome Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 UNITED STATES SJOGREN’S SYNDROME MANUFACTURERS PROFILES/ANALYSIS

6.1 Astellas Pharma
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Sjogren’s Syndrome Product Type, Application and Specification
    6.1.2.1 Biologic immunosuppressant drugs
    6.1.2.2 Others
  6.1.3 Astellas Pharma Sjogren’s Syndrome Sales, Revenue, Price and Gross Margin (2011-2016)
  6.1.4 Main Business/Business Overview
6.2 Roche
  6.2.2 Sjogren’s Syndrome Product Type, Application and Specification
    6.2.2.1 Biologic immunosuppressant drugs
    6.2.2.2 Others
  6.2.3 Roche Sjogren’s Syndrome Sales, Revenue, Price and Gross Margin (2011-2016)
  6.2.4 Main Business/Business Overview
6.3 Novartis
  6.3.2 Sjogren’s Syndrome Product Type, Application and Specification
    6.3.2.1 Biologic immunosuppressant drugs
    6.3.2.2 Others
  6.3.3 Novartis Sjogren’s Syndrome Sales, Revenue, Price and Gross Margin (2011-2016)
  6.3.4 Main Business/Business Overview
6.4 Pfizer
  6.4.2 Sjogren’s Syndrome Product Type, Application and Specification
    6.4.2.1 Biologic immunosuppressant drugs
    6.4.2.2 Others
  6.4.3 Pfizer Sjogren’s Syndrome Sales, Revenue, Price and Gross Margin (2011-2016)
  6.4.4 Main Business/Business Overview
6.5 GSK
  6.5.2 Sjogren’s Syndrome Product Type, Application and Specification
    6.5.2.1 Biologic immunosuppressant drugs
    6.5.2.2 Others
  6.5.3 GSK Sjogren’s Syndrome Sales, Revenue, Price and Gross Margin (2011-2016)
  6.5.4 Main Business/Business Overview
6.6 Genzyme (Sanofi)?
  6.6.2 Sjogren’s Syndrome Product Type, Application and Specification
    6.6.2.1 Biologic immunosuppressant drugs
    6.6.2.2 Others
  6.6.3 Genzyme (Sanofi)? Sjogren’s Syndrome Sales, Revenue, Price and Gross Margin (2011-2016)
  6.6.4 Main Business/Business Overview

7 SJOGREN’S SYNDROME MANUFACTURING COST ANALYSIS

7.1 Sjogren’s Syndrome Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Sjogren’s Syndrome

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Sjogren’s Syndrome Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Sjogren’s Syndrome Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES SJOGREN’S SYNDROME MARKET FORECAST (2016-2021)

11.1 United States Sjogren’s Syndrome Sales, Revenue Forecast (2016-2021)
11.2 United States Sjogren’s Syndrome Sales Forecast by Type (2016-2021)
11.3 United States Sjogren’s Syndrome Sales Forecast by Application (2016-2021)
11.4 Sjogren’s Syndrome Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Sjogren’s Syndrome
Table Classification of Sjogren’s Syndrome
Figure United States Sales Market Share of Sjogren’s Syndrome by Type in 2015
Figure Biologic immunosuppressant drugs Picture
Figure Others Picture
Table Application of Sjogren’s Syndrome
Figure United States Sales Market Share of Sjogren’s Syndrome by Application in 2015
Figure Eye care Examples
Figure Vaginal dryness Examples
Figure Musculoskeletal Examples
Figure Systemic Examples
Figure Dental care Examples
Figure United States Sjogren’s Syndrome Sales and Growth Rate (2011-2021)
Figure United States Sjogren’s Syndrome Revenue and Growth Rate (2011-2021)
Table United States Sjogren’s Syndrome Sales of Key Manufacturers (2015 and 2016)
Table United States Sjogren’s Syndrome Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Sjogren’s Syndrome Sales Share by Manufacturers
Figure 2016 Sjogren’s Syndrome Sales Share by Manufacturers
Table United States Sjogren’s Syndrome Revenue by Manufacturers (2015 and 2016)
Table United States Sjogren’s Syndrome Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Sjogren’s Syndrome Revenue Share by Manufacturers
Table 2016 United States Sjogren’s Syndrome Revenue Share by Manufacturers
Table United States Market Sjogren’s Syndrome Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Sjogren’s Syndrome Average Price of Key Manufacturers in 2015
Figure Sjogren’s Syndrome Market Share of Top 3 Manufacturers
Figure Sjogren’s Syndrome Market Share of Top 5 Manufacturers
Table United States Sjogren’s Syndrome Sales by States (2011-2016)
Table United States Sjogren’s Syndrome Sales Share by States (2011-2016)
Figure United States Sjogren’s Syndrome Sales Market Share by States in 2015
Table United States Sjogren’s Syndrome Revenue and Market Share by States (2011-2016)
Table United States Sjogren’s Syndrome Revenue Share by States (2011-2016)
Figure Revenue Market Share of Sjogren’s Syndrome by States (2011-2016)
Table United States Sjogren’s Syndrome Price by States (2011-2016)
Table United States Sjogren’s Syndrome Sales by Type (2011-2016)
Table United States Sjogren’s Syndrome Sales Share by Type (2011-2016)
Figure United States Sjogren’s Syndrome Sales Market Share by Type in 2015
Table United States Sjogren’s Syndrome Revenue and Market Share by Type (2011-2016)
Table United States Sjogren’s Syndrome Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Sjogren’s Syndrome by Type (2011-2016)
Table United States Sjogren’s Syndrome Price by Type (2011-2016)
Figure United States Sjogren’s Syndrome Sales Growth Rate by Type (2011-2016)
Table United States Sjogren’s Syndrome Sales by Application (2011-2016)
Table United States Sjogren’s Syndrome Sales Market Share by Application (2011-2016)
Figure United States Sjogren’s Syndrome Sales Market Share by Application in 2015
Table United States Sjogren’s Syndrome Sales Growth Rate by Application (2011-2016)
Figure United States Sjogren’s Syndrome Sales Growth Rate by Application (2011-2016)
Table Astellas Pharma Basic Information List
Table Astellas Pharma Sjogren’s Syndrome Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Astellas Pharma Sjogren’s Syndrome Sales Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Sjogren’s Syndrome Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Sjogren’s Syndrome Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Sjogren’s Syndrome Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Sjogren’s Syndrome Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Sjogren’s Syndrome Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Sjogren’s Syndrome Sales Market Share (2011-2016)
Table GSK Basic Information List
Table GSK Sjogren’s Syndrome Sales, Revenue, Price and Gross Margin (2011-2016)
Table GSK Sjogren’s Syndrome Sales Market Share (2011-2016)
Table Genzyme (Sanofi)? Basic Information List
Table Genzyme (Sanofi)? Sjogren’s Syndrome Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genzyme (Sanofi)? Sjogren’s Syndrome Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Sjogren’s Syndrome
Figure Manufacturing Process Analysis of Sjogren’s Syndrome
Figure Sjogren’s Syndrome Industrial Chain Analysis
Table Raw Materials Sources of Sjogren’s Syndrome Major Manufacturers in 2015
Table Major Buyers of Sjogren’s Syndrome
Table Distributors/Traders List
Figure United States Sjogren’s Syndrome Production and Growth Rate Forecast (2016-2021)
Figure United States Sjogren’s Syndrome Revenue and Growth Rate Forecast (2016-2021)
Table United States Sjogren’s Syndrome Production Forecast by Type (2016-2021)
Table United States Sjogren’s Syndrome Consumption Forecast by Application (2016-2021)
Table United States Sjogren’s Syndrome Sales Forecast by States (2016-2021)
Table United States Sjogren’s Syndrome Sales Share Forecast by States (2016-2021)